Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03529565 · ClinicalTrials.gov registry record
Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 17
- Enrollment target
NCT03529565 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 17 participants.
The verdict
NCT03529565 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This trial studies histamine and bone pain association in participants with breast cancer that has spread to the bone. Studying histamine levels in samples of blood from participants with breast cancer in the laboratory may help doctors learn more about reducing cancer bone pain and preventing further bone metastasis.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Quality-of-Life Assessment
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-01-31 |
| Est. Completion | 2024-09-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03529565
The ClinicalTrials.gov registry entry for NCT03529565 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT03529565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03529565 about?
NCT03529565 is a clinical study titled "Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone". This trial studies histamine and bone pain association in participants with breast cancer that has spread to the bone. Studying histamine levels in samples of blood from participants with breast cancer in the laboratory may help doctors learn more about reducing cancer bone pain and preventing furth...
What is the current status of trial NCT03529565?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2019-01-31. Estimated completion is 2024-09-18.
What interventions are being tested in trial NCT03529565?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Quality-of-Life Assessment (OTHER), Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT03529565?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.